2023, Packaging and Vaccines - Pharmacy Technician Pulse

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

AUGUST 5, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News GSK’s world-first gonorrhoea vaccine launched in England The immunisation programme aims to reduce rising gonorrhoea rates and address antibiotic-resistant strains. GSK’s 4CMenB is not a newly approved vaccine.

Vaccines

Vaccines Communication Hospitals Packaging

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines

Vaccines Independent Pharmacies Immunization Compounding

ICH Q6B for Analytics

PharmTech

JUNE 6, 2025

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. Analytical Validation (ICH, 2023). Easton, R.L. Structural Characterization Methods for Biosimilars: Fit-for-Purpose, Qualified, or Validated.

Dosage

Dosage Documentation Labelling FDA

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

JULY 19, 2025

While the results of this study were presented at the American College of Cardiology meeting in 2023, the completed study results have yet to be published. 17 A phase 3 trial with baxdrostat (BaxHTN) in resistant hypertension was started in November 2023 with an unknown completion date. JAMA 2023; 330:1140-1150.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Vaccines Immunization

3 of the year’s most notable FDA nods

PharmaVoice

JUNE 27, 2025

Of the 13 antibiotics OK’d for the market between mid-2017 and 2023, only two belonged to a new class of drugs, the WHO reported last year. A long-time leader in vaccines, the U.K. The pharma struck a development deal for Datroway worth up to $1 billion up front in 2020 and has estimated its peak sales could reach $5 billion.

FDA

FDA Vaccines Packaging Dosage

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Pharmacy Times

JULY 7, 2025

1,3 According to the package insert for Gammagard Liquid ERC, it is contraindicated in patients with severe systemic hypersensitivity or anaphylactic reactions to the product.

FDA

FDA Immunization Compounding Pharmacies Hospitals

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmTech

JUNE 23, 2025

From the Dilantin package insert: “The free acid form of phenytoin is used in DILANTIN-125 Suspension and DILANTIN Infatabs. Guidance for Industry, Q9(R1) Quality Risk Management (CDER/CBER, May 2023). Selecting of the appropriate pharmaceutical alternative requires technical judgment. USDOJ.gov , May 2006 (accessed April 29, 2025).

Compounding

Compounding Dosage Labelling FDA

PillPack from Amazon Pharmacy Expands to Medicare Part D: How PillPack and 24/7 Support Are Transforming Medication Access and Adherence

Pharmacy Times

JULY 15, 2025

What we've done is blend PillPack's innovative packaging with Amazon Pharmacy's user-friendly approach and affordability, so these patients can now get their medications in convenient, personalized packets and order everything online through our digital pharmacy. Subscribe Now!

Compounding Pharmacies

Compounding Pharmacies Vaccines Medication Delivery Hospitals

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives.

Packaging

Packaging Chemotherapy Communication Hospitals

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Pharmacy Times

JUNE 5, 2025

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 2 A prominent aspect of this issue that manufacturers have tried to tackle is medication recognition when transferring pills to containers and packaging. 1-3 Detect-A-Dose Lid Label Covers.

Packaging

Packaging Labelling Compounding Pharmacies Immunization

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Reports Future of Pharma - Looking Ahead to 2023 Data Insights The gold standard of business intelligence. According to a Reuters article, pharma companies launched new US drugs at prices 35% higher in 2023, compared to those launched in 2022.

Chemotherapy

Chemotherapy Packaging Communication Hospitals

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Pharmacy Times

JUNE 23, 2025

Along with the successful pivotal trials, Launch-HTN and Advance-HTN, and the ongoing open-label extension trial, these results comprise the core package for our planned NDA submission.” Explore-CKD established that lorundrostat 25 mg once daily has a favorable clinical profile for this patient population.

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Compounding

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

Pharmacy Times

JULY 3, 2025

It's cognitive behavioral therapy packaged as a digital experience. I've even seen VR experiences, so it can be packaged in any type of digital experience. Areo Nazari, PharmD: PDTs are digital or software-based treatments that are approved by the FDA to treat disease.

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Packaging

HIV Reporting Meets the Front Line: How Pharmacists Translate Global Health Into Local Care

Pharmacy Times

JULY 17, 2025

In June 2025, the White House submitted a formal rescissions package to Congress that proposed eliminating billions in foreign aid funding—including over $8 billion allocated to USAID. Most notably, they threaten research intended to develop the first HIV vaccine. Associated Press. July 17, 2025. Accessed July 17, 2025. May 30, 2025.

Vaccines

Vaccines Compounding Pharmacies Compounding Immunization

Sustainable Alternative: PFAS-Free-TPE for Pharmaceutical Stoppers

PharmTech

AUGUST 11, 2025

SHOW MORE Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more sustainable product. Needle of a syringe protrudes through the rubber cap of a vaccine vial with red cap. pharmaceutical packaging where PFAS may be used to treat rubber components).

Packaging

Packaging Dosage Vaccines FDA

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Pharmacy Times

JUNE 11, 2025

Package insert. FDA approves tablet formulation of BeOne's BRUKINSA for all approved indications. News Release. Released June 11, 2025. Accessed June 11, 2025. BeiGene USA, Inc.; Accessed June 11, 2025.

FDA

FDA Compounding Pharmacies Immunization Specialty Pharmacies

CDC Report Finds No Connection Between Thimerosal and Autism

Drug Topics

JUNE 25, 2025

In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.

Vaccines

Vaccines Independent Pharmacies Immunization Compounding

Merck agrees to acquire Verona Pharma for $10bn

Pharmaceutical Technology

JULY 10, 2025

How will RFK Jr’s American dream for vaccines play out? The acquisition is Merck’s first of 2025 and is its largest since the $10.8bn acquisition of Prometheus Biosciences in 2023. Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. Sign up for our daily news round-up!

Packaging

Packaging Hospitals Communication FDA

PODD 2025 Unveils Agenda Highlighting Innovation in Drug Delivery Technologies

PharmTech

JULY 16, 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Dosage

Dosage Packaging Vaccines FDA

Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention

Pharmaceutical Technology

JULY 2, 2025

How will RFK Jr’s American dream for vaccines play out? Antiviral Biktarvy is the company’s top-selling HIV drug, generating global revenue of $13.4bn in 2024, an increase of 13% compared to 2023. Gilead already has several approved HIV treatments and prevention options in the US. Sign up for our daily news round-up!

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Packaging FDA Communication

CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies

PharmTech

JUNE 12, 2025

While BioNTech is best known for co-developing the first approved mRNA vaccine with Pfizer, the company continues to invest heavily in mRNA research targeting various solid tumors and infectious diseases. Its technology platforms are built to enhance immunogenicity while maintaining low-dose efficiency—a key factor for scalability and safety.

Dosage

Dosage Vaccines Packaging Compounding

FDA’s new mission to speed drug reviews

PharmaVoice

JUNE 30, 2025

questions vaccine evidence By Delilah Alvarado Explore About Editorial Team Contact Us Newsletter Purchase Licensing Rights Press Releases Reach our audience Advertising Post a press release Promote an event Industry Dive is an Informa TechTarget business.

FDA

FDA Packaging Vaccines

Health Canada extends Evkeeza approval for children with HoFH

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? This decision follows the initial approval granted in September 2023, which covered patients aged five and above. Go deeper with GlobalData Reports LOA and PTSR Model - Evinacumab in Heterozygous familial hyperchole. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Vaccines

Uncertainty looms over FDA scheme to boost US manufacturing

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Uncertainty looms over FDA scheme to boost US manufacturing The FDA’s new PreCheck programme is aimed at facilitating the introduction of new US drug manufacturing facilities. Data Insights The gold standard of business intelligence.

FDA

FDA Packaging Communication Hospitals

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

JULY 2, 2025

How will RFK Jr’s American dream for vaccines play out? The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed.

Packaging

Packaging Compounding Communication FDA

NSW government invests $13.39m in life-changing therapies

Pharmaceutical Technology

JUNE 20, 2025

The latest funding boost supplements an earlier announcement made during the 2023-24 budget, which provided A$25m in recurrent funding dedicated to similar initiatives. The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network.

Hospitals

Hospitals Communication Immunization Packaging

The unsustainability of clinical trials and need for transformative change

Pharmaceutical Technology

JULY 11, 2025

How will RFK Jr’s American dream for vaccines play out? 3 GlobalData’s analysis shows that the number of clinical trial investigators globally fell from approximately 128,303 in 2017-18 to 116,948 in 2023-24 – a decline of almost 10%.

Hospitals

Hospitals FDA Medical Records Packaging

Subcutaneous Biologics Market Analysis: Current Trends and Future Outlook

Roots Analysis

JANUARY 27, 2025

It is important to note that, for the purpose of subcutaneous biologics market analysis, the biologics were segregated into antibodies , nucleotides, proteins and vaccines. The below figure presents the distribution of subcutaneous biologics based on initial approval year and type of biologic.

Hospitals

Hospitals Packaging Compounding Immunization

New US-EU trade deal on tariffs ends pharma’s geopolitical immunity

Pharmaceutical Technology

AUGUST 5, 2025

Go deeper with GlobalData Reports State of the Biopharmaceutical Industry 2023 Reports Greece Healthcare (Pharma and Medical Devices) Market Analysis, Reg. The 15% tariff is not expected to happen immediately as implementation will be dependent on a National Security investigation regarding pharmaceutical imports.

Immunization

Immunization Pharmaceutical Companies Pharmaceutical Companies Communication

JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

Pharmaceutical Technology

JULY 9, 2025

How will RFK Jr’s American dream for vaccines play out? The first collaboration was announced in March 2023 for neurodegenerative diseases, and the second in December 2023 focused on discovering oligonucleotide therapeutics. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? In 2024, the US Food and Drug Administration (FDA) approved 19 biosimilars – a significant increase from the five approved in 2023. By inhibiting RANKL, denosumab hampers the bone degradation process, bolstering bone density and strength. Sign up for our daily news round-up!

Chemotherapy

Chemotherapy Packaging Communication Hospitals

Gilead hit with FDA clinical hold for batch of HIV trials

Pharmaceutical Technology

JUNE 11, 2025

Antiviral Biktarvy is the company’s top-selling HIV drug, generating global revenue of $13.4bn in 2024, an increase of 13% compared to 2023. Gilead already has several approved HIV treatments and prevention options in the US. Give your business an edge with our leading industry insights.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents FDA Communication Hospitals

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? In 2023, AstraZeneca licensed LM-305, a G-protein targeting-ADC, for $600m. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates.

Packaging

Packaging Communication Hospitals Vaccines

Elkedonia Raises €11.25M Seed Round to Advance Neuroplastogen Therapy for Depression

PharmTech

JUNE 11, 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Dosage

Dosage Packaging Vaccines Compounding

Astria Therapeutics licenses navenibart rights to Kaken for HAE

Pharmaceutical Technology

AUGUST 7, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Astria Therapeutics licenses navenibart rights to Kaken for HAE Astria will receive $16m upfront and is eligible for a further $16m in commercialisation and sales milestones. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Immunization Hospitals

Theratechnologies shares surge 25% amid $254m Future Pak takeover

Pharmaceutical Technology

JULY 3, 2025

How will RFK Jr’s American dream for vaccines play out? accumulated in 2023. In April 2025, Future Pak tabled a $255 offer, which has now been accepted by the drugmaker. Theratechnologies reported 2024 revenue of $85.9m, a 5% increase from the $81.8m Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

FDA Publishes More Than 200 Complete Response Letters

PharmTech

JULY 11, 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

FDA

FDA Dosage Vaccines Packaging

J&J eyes prostate cancer label expansion for Akeega

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? Akeega has been approved in Europe for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with steroid hormone prednisolone since 2023. Go deeper with GlobalData Reports LOA and PTSR Model - (Abiraterone Acetate + Niraparib) in Metastati.

Labelling

Labelling Packaging Communication Hospitals

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

Pharmaceutical Technology

JUNE 13, 2025

Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates. For deals specific to US companies, the analysis found that total deal value rose from $15.7bn in 2023 to $21.3bn in 2024.

Communication

Communication Hospitals Vaccines Packaging

FDA Shake-Up: Vinay Prasad Exits Amid Tumult in Biologics Oversight

PharmTech

JULY 30, 2025

SHOW MORE Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash. He had just begun advancing a regulatory overhaul that emphasized tighter standards for product review—especially around COVID-19 vaccines and cell and gene therapies (1). EndpointNews.com.

FDA

FDA Dosage Vaccines Packaging

Manufacturing issues at Novo facility disrupt Regeneron drug review

Pharmaceutical Technology

AUGUST 4, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Manufacturing issues at Novo facility disrupt Regeneron drug review Issues were picked up during an FDA inspection of Novo Nordisk-owned Catalent’s mammoth filling plant. Regeneron’s problems with Catalent’s filling site are not unexpected.

FDA

FDA Communication Hospitals Packaging

FDA approves Dizal’s Zegfrovy to treat adults with NSCLC

Pharmaceutical Technology

JULY 3, 2025

How will RFK Jr’s American dream for vaccines play out? In August 2023, Zegfrovy received clearance in China based on results from another significant trial, WU-KONG6. Dizal recently completed patient enrolment for its Phase III WU-KONG28 study spanning 16 countries and regions. Sign up for our daily news round-up!

FDA

FDA Packaging Communication Hospitals

How to remain a top CDMO in ADC-led oncology

Pharmaceutical Technology

JULY 10, 2025

How will RFK Jr’s American dream for vaccines play out? Yet by 2023, the market value had risen to $9.2bn. Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. The ADCs market growth is considerable. In 2011, the market was worth an estimated $50m.

Communication

Communication Packaging Vaccines Hospitals

Can China sustain a surge in oncology drug innovation?

PharmaVoice

JULY 2, 2025

In 2023 and 2024, approximately 30% of molecules in-licensed by Big Pharma companies came from China, Lansdell said. The country’s trajectory may get a boost from anticipated results of a Keytruda rival’s U.S. Western drugmakers have taken notice of the country’s advances and dealmaking is booming.

Packaging

Packaging FDA Immunization Vaccines

GSK’s world-first gonorrhoea vaccine launched in England

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Trending Sources

ICH Q6B for Analytics

Hypertension: A Silent Killer Requiring Novel Therapies

3 of the year’s most notable FDA nods

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PillPack from Amazon Pharmacy Expands to Medicare Part D: How PillPack and 24/7 Support Are Transforming Medication Access and Adherence

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Big pharma braces for revenue headwinds as patent expiries loom

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

HIV Reporting Meets the Front Line: How Pharmacists Translate Global Health Into Local Care

Sustainable Alternative: PFAS-Free-TPE for Pharmaceutical Stoppers

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

CDC Report Finds No Connection Between Thimerosal and Autism

Merck agrees to acquire Verona Pharma for $10bn

PODD 2025 Unveils Agenda Highlighting Innovation in Drug Delivery Technologies

Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention

CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies

FDA’s new mission to speed drug reviews

Health Canada extends Evkeeza approval for children with HoFH

Uncertainty looms over FDA scheme to boost US manufacturing

Cell and gene therapy: The vital role of logistics

NSW government invests $13.39m in life-changing therapies

The unsustainability of clinical trials and need for transformative change

Subcutaneous Biologics Market Analysis: Current Trends and Future Outlook

New US-EU trade deal on tariffs ends pharma’s geopolitical immunity

JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Gilead hit with FDA clinical hold for batch of HIV trials

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Elkedonia Raises €11.25M Seed Round to Advance Neuroplastogen Therapy for Depression

Astria Therapeutics licenses navenibart rights to Kaken for HAE

Theratechnologies shares surge 25% amid $254m Future Pak takeover

FDA Publishes More Than 200 Complete Response Letters

J&J eyes prostate cancer label expansion for Akeega

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

FDA Shake-Up: Vinay Prasad Exits Amid Tumult in Biologics Oversight

Manufacturing issues at Novo facility disrupt Regeneron drug review

FDA approves Dizal’s Zegfrovy to treat adults with NSCLC

How to remain a top CDMO in ADC-led oncology

Can China sustain a surge in oncology drug innovation?

Stay Connected